Browsing eNauka
Browsing by Project Summit Therapeutics, Inc.
Showing results 1 to 1 of 1
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | A randomized phase 3 study of ivonescimab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of metastatic non-small cell lung cancer: HARMONi-3. | Zhang, Jianjun; ...; Andric, Zoran   ; ...; (broj, koautora 20) | Conference Paper | Mp. category will be shown later |